SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (3818)5/3/1998 12:21:00 AM
From: LoLoLoLita   of 7041
 
Hank,

Agree fully. Further, if ZONA has a poster presenting those results without a full explanation of how they were obtained, it could well be interpreted by FDA staff as ZONA "promoting" a drug without supporting scientific data, a potential violation of FDA regulations.

However, just because this info does not appear to be in the poster itself, there is no rule or custom to prevent a presenter from offering additional information, such as a technical report, to the people walking by. If I was an FDA staffer responsible for handling ED NDAs, I'd be very concerned if ZONA presented these claims without, at a minimum, a detailed written report describing their protocol.

Even then. a ZONA/SGP technical report would not be considered to be peer-reviewed, so even with that they might get into problems.

I'm sure that at least one FDA staffer will attend the AUA meeting, due to the "Viagra phenomenon."

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext